Cover Image
市場調查報告書

美國的胰島素幫浦及持續葡萄糖監測(CGM)市場:各用戶、各州的醫療費償付制度、糖尿病人口(第一型、第2型)、契約類型、臨床實驗、預測

USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast

出版商 Renub Research 商品編碼 543296
出版日期 內容資訊 英文 133 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的胰島素幫浦及持續葡萄糖監測(CGM)市場:各用戶、各州的醫療費償付制度、糖尿病人口(第一型、第2型)、契約類型、臨床實驗、預測 USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast
出版日期: 2017年08月10日 內容資訊: 英文 133 Pages
簡介

本報告提供美國的胰島素幫浦及葡萄糖監測(CGM)市場相關調查,關於糖尿病人口及胰島素幫浦/CGM用戶數的變化與預測,成長要素以及課題分析,主要產品的特徵,各州、保險公司的醫療償付制度概要,臨床試驗趨勢,主要企業簡介等總括性彙整。

第1章 摘要整理

第2章 美國的糖尿病人口

  • 糖尿病人口的變化與預測
  • 第一型糖尿病
  • 第二型糖尿病

第3章 美國的胰島素幫浦用戶

  • 第一型糖尿病的用戶
  • 第二型糖尿病的用戶

第4章 美國的胰島素幫浦市場

  • 第一型糖尿病胰島素幫浦市場
  • 第二型糖尿病胰島素幫浦市場

第5章 美國的持續葡萄糖測量儀(CGM)用戶數的變化與預測

第6章 美國的持續葡萄糖測量儀(CGM)市場預測

第7章 胰島素幫浦的差異化:各產品

  • Animas Vibe
  • Medtronic 530G with Enlite
  • Insulet OmniPod
  • Tandem t:slim
  • Roche Accu-Chek Combo

第8章 患者及醫療專家作為對象的訓練模式

  • Medtronic
  • Insulet Corporation
  • Animas Corporation
  • Tandem Diabetes Care

第9章 糖尿病相關用品的醫療費償付制度:各州

  • 加州
  • 特拉華州
  • 俄亥俄州
  • 佛羅里達州
  • 麻薩諸塞州
  • 密西根州
  • 蒙大拿州
  • 內布拉斯加州
  • 紐澤西州
  • 紐約州
  • 奧克拉荷馬州
  • 羅德島州
  • 南達科他州
  • 田納西州
  • 德克薩斯州
  • 華盛頓州

第10章 胰島素幫浦及CGM的醫療費償付制度:各保險公司

  • Blue Cross and Blue Shield
  • Aetna
  • Cigna
  • United Healthcare

第11章 美國的胰島素幫浦市場:各契約

  • 合作
  • 製造委託契約
  • 授權合約
  • 獨佔契約
  • 合作關係

第12章 胰島素幫浦的臨床試驗

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care
  • Roche
  • Animas Corporation

第13章 主要企業簡介

  • Medtronic
  • Insulet Corporation
  • Roche
  • Animas Corporation
  • Tandem Diabetes Care

第15章 成長要素

  • 與胰島素的頻繁注射比較的胰島素幫浦的優點
  • 適合生活習慣的治療方法的選項 & 胰島素幫浦的技術進步

第16章 課題

  • 胰島素幫浦的安全方面的問題
  • 胰島素幫浦相關的課題
    • 體重增加
    • 糖尿病酮酸症
    • 感染疾病 & 急性輸液反應
  • 投藥持續率

圖表

目錄

USA insulin pump market is expected to grow more than US$ 5 Billion by the end of year 2022 . The convenience of using insulin pump are gaining inclusive acceptance in the market as insulin delivery systems. Now insulin Pump has become famous and a preferred device for Type1 diabetes patients in the United States. Insulin Pump market constitutes comparatively small portion of total Insulin Delivery Systems market.

United States CGM (Continuous Glucose Monitoring) Market to be more than US$ 2 Billion in Future

USA CGM market has a huge potential in future. Continuous Glucose Monitoring users have grown with 35 percent in 2016 from its users in 2009 . United States CGM market hold immense potential in future as many private insurer starts reimbursing CGM in United States based on certain criteria. Many experts in United States believe that CGM is best tool for diabetes management. CGM is compatible for those having several diabetes complications occurring frequently.

Reimbursements of Insulin Pumps, CGM, Diabetes Supplies in USA by States

All state law diabetes mandates and minimum coverage requirements for state-regulated health insurance policies. Almost every state provides diabetes supplies to their citizen but not all state provide insulin pump coverage. In our research report we have covered many State sponsored programmes, which covers insulin pumps under equipment and supplies. The report also provides reimbursement details on the CGM if it is covered by federal health plan as well as State-sponsored health plan. Many private insurers also provide coverage to the CGM cost based on the medical necessity and requirement, details given in the report.

Training Model of Insulin Pump provided by leading Companies Medtronic, Insulet Corporation, Animas Corporation & Tandem Diabetes Care is covered in this report

Although comprehensive training is provided to new patients by healthcare providers, diabetes educator and certified product trainer and dietician etc. but companies are also providing training to the new pump user via online portal to review the training materials. In addition companies are also providing training and training material to the Health Care Professional (HCP). Read the complete flow chart of training model of all the 4 companies Medtronic, Insulet Corporation, Animas Corporation & Tandem Diabetes Care in the report.

Renub Research latest study "USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast " provides a detailed and comprehensive insight of the Insulin Pump & CGM (Continuous Glucose Monitoring) Market in United States.

Scope of the Report

  • Insulin Pump Market & Forecast : We have divided Insulin Pump Market into two part United States Type 1 Diabetes Market / Juvenile Diabetes Market and United States Type 2 Diabetes Market. Market data from 2009 to 2016 and Forecast from 2017 to 2022.
  • CGM (Continuous Glucose Monitoring) Market & Forecast : Report provides the data on United States CGM market from 2009 to 2016 and Forecast from 2017 to 2022.
  • Insulin Pump Users & Forecast : We have divided Insulin Pump Users into two part United States Type 1 Diabetes Users / Juvenile Diabetes Users and United States Type 2 Diabetes Users. Number of Users data from 2009 to 2016 and Forecast from 2017 to 2022.
  • CGM (Continuous Glucose Monitoring) Market & Forecast : Report provides the data on United States CGM users from 2009 to 2016 and Forecast from 2017 to 2022.
  • Reimbursement Policy of USA States : Report provides details on USA States reimbursement policy for Insulin Pumps, CGM (Continuous Glucose Monitoring), Diabetes Supplies (Blood Glucose Devices, Test Strips, Lancets, Disposable Needles, Syringe, Ketone Urine Testing Strips, Pen Delivery, Podiatric Appliances, Oral Agents for controlling blood sugars) has been captured in the report.
  • Reimbursement Policy of USA Insurance Companies : Report captures reimbursement policy of 4 top insurance companies Blue Cross and Blue Shield, Aetna, Cigna and United Healthcare for insulin Pumps and CGM (Continuous Glucose Monitoring).
  • Training Models : Under this segment companies Training program for its staff includes physicians, Certified Diabetes Educators (including nurse educators, dietitians and exercise physiologists) and support staff with expertise in insulin pump therapy and Training program for patients have been described through flow chart method. In total 4 companies Medtronic, Insulet Corporation, Animas Corporation & Tandem Diabetes Care Training program has been studied in the report.
  • Differentiation Points of Insulin Pump Products : This topic discusses the Advantages and Drawbacks of the following insulin pumps: Animas Vibe, Medtronic 530G with Enlite, Insulet OmniPod, Tandem t:slim, Roche Accu-Chek Combo.
  • Major Deal Types : Major global deals of insulin pump including Collaboration Deals, Manufacturing Agreement, Licensing Agreement, Exclusive Agreement and Partnership Deals are mentioned in this report.
  • Clinical Trials of Insulin Pumps : Report captures details of clinical trials results for companies on Insulin Pumps. The report captures details of the following companies Medtronic, Insulet Corporation, Tandem Diabetes Care, Roche and Animas Corporation.
  • Companies Analysis : All the 5 companies have been covered from the following points: Overview, Product Details, Insulin Pump Sales Analysis and Latest Development & Trends in their insulin pumps. The five companies studied in the report are as follows: Medtronic, Insulet Corporation, Roche, Animas Corporation (Acquired by Johnson & Johnson) and Tandem Diabetes Care
  • Growth Drivers for Insulin Pumps : This topic studies the factors which is helping the Insulin Pump and CGM (Continuous Glucose Monitoring) industry to grow.
  • Challenges for Insulin Pumps : This industry shows the problems being faced by the insulin Pump and CGM (Continuous Glucose Monitoring) industry.

Key Companies Covered

  • 1. Medtronic
  • 2. Animas Corporation
  • 3. Insulet Corporation
  • 4. Roche
  • 5. Tandem Diabetes Care

Key Questions Answered in the Report?

What is the Insulin Pump Therapy Market in United States & its growth potential in Future? What is the Continuous Glucose Monitor Market in United States & its growth potential in Future? What is the number of Type 1 and Type 2 Diabetes patients that use insulin pump? What is the number of CGM patients in United States and its Forecast? What is the preferred brand of insulin pump in United States? Is Insulin Pump Therapy Treatment being covered in the Reimbursement policy of United States? What are the major deals of insulin pump? What are the latest clinical trials of insulin pump? What are the key growth drivers and challenges of insulin pump?

Table of Contents

1. Executive Summary

2. USA - Diabetes Population (2009 - 2022)

  • 2.1 Diabetes Population (2009 - 2022)
  • 2.2 Type 1 Diabetes (Juvenile Diabetes) Population (2009 - 2022)
  • 2.3 Type 2 Diabetes Population (2009 - 2022)

3. United States - Insulin Pump User (2009 - 2022)

  • 3.1 United States - Insulin Pump Type 1 User (2009 - 2022)
  • 3.2 United States - Insulin Pump Type 2 User (2009 - 2022)

4. USA - Insulin Pump Market (2009 - 2022)

  • 4.1 USA - Insulin Pump Type 1 Market (2009 - 2022)
  • 4.2 United States - Insulin Pump Type 2 Market (2009 - 2022)

5. USA - CGM (Continuous Glucose Monitoring) User (2009 - 2022)

6. USA - CGM (Continuous Glucose Monitoring) Market & Forecast

7. Differentiation Points of Insulin Pump Products in United States

  • 7.1 Animas Vibe
  • 7.2 Medtronic 530G with Enlite
  • 7.3 Insulet OmniPod
  • 7.4 Tandem t:slim
  • 7.5 Roche Accu-Chek Combo

8. Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

  • 8.1 Medtronic
    • 8.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
    • 8.1.2 Training Model for HCP (HealthCare Professional)
  • 8.2 Insulet Corporation
    • 8.2.1 Training Structure for New Patients - Insulet Corporation
  • 8.3 Animas Corporation
    • 8.3.1 Training Modules for New Patients
    • 8.3.2 Training Modules for HCP (Health Care Professional)
  • 8.4 Tandem Diabetes Care

9. USA (By States) - Diabetes Supplies, Insulin Pump & Pump Supplies Reimbursement Policies by State-Sponsored Health Program

  • 9.1 CALIFORNIA
    • 9.1.1 People Covered by Insurance Mandates
    • 9.1.2 Equipment and Supplies
    • 9.1.3 Services
  • 9.2 DELAWARE
    • 9.2.1 People Covered by Insurance Mandates
    • 9.2.2 Equipment and Supplies
    • 9.2.3 Services
  • 9.3 FLORIDA
    • 9.3.1 People Covered by Insurance Mandates
    • 9.3.2 Equipment and Supplies
    • 9.3.3 Services
  • 9.4 MASSACHUSETTS
    • 9.4.1 People Covered by Insurance Mandates
    • 9.4.2 Equipment and Supplies
    • 9.4.3 Services
  • 9.5 MICHIGAN
    • 9.5.1 People Covered by Insurance Mandates
    • 9.5.2 Equipment and Supplies
    • 9.5.3 Services
  • 9.6 MONTANA
    • 9.6.1 People Covered by Insurance Mandates
    • 9.6.2 Equipment and Supplies
    • 9.6.3 Services
  • 9.7 NEBRASKA
    • 9.7.1 People Covered by Insurance Mandates
    • 9.7.2 Equipment and Supplies
    • 9.7.3 Services
  • 9.8 NEW JERSEY
    • 9.8.1 People Covered by Insurance Mandates
    • 9.8.2 Equipment and Supplies
    • 9.8.3 Services
  • 9.9 NEW YORK
    • 9.9.1 People Covered by Insurance Mandates
    • 9.9.2 Equipment and Supplies
    • 9.9.3 Services
  • 9.10 OKLAHOMA
    • 9.10.1 People Covered by Insurance Mandates
    • 9.10.2 Equipment and Supplies
    • 9.10.3 Services
  • 9.11 RHODE ISLAND
    • 9.11.1 People Covered by Insurance Mandates
    • 9.11.2 Equipment and Supplies
    • 9.11.3 Services
  • 9.12 SOUTH DAKOTA
    • 9.12.1 People Covered by Insurance Mandates
    • 9.12.2 Equipment and Supplies
    • 9.12.3 Services
  • 9.13 TENNESSEE
    • 9.13.1 People Covered by Insurance Mandates
    • 9.13.2 Equipment and Supplies
    • 9.13.3 Services
  • 9.14 TEXAS
    • 9.14.1 People Covered by Insurance Mandates
    • 9.14.2 Equipment and Supplies
    • 9.14.3 Services:
  • 9.15 WASHINGTON
    • 9.15.1 People Covered by Insurance Mandates
    • 9.15.2 Equipment and Supplies
    • 9.15.3 Services

10. Top Private Insurer - Reimbursement Policy of Insulin Pump and CGM

  • 10.1 Blue Cross and Blue Shield
    • 10.1.1 Insulin Pump Reimbursement
    • 10.1.2 CGM Reimbursement
  • 10.2 Aetna
    • 10.2.1 Insulin Pump Reimbursement
    • 10.2.2 CGM Reimbursement
  • 10.3 Cigna
    • 10.3.1 Insulin Pump Coverage Policy
    • 10.3.2 CGM Reimbursement Policy
  • 10.4 United Healthcare
    • 10.4.1 Insulin Pump Reimbursement Policy
    • 10.4.2 CGM Reimbursement policy

11. By Company - USA Insulin Pump Market Share

12. USA Insulin Pump Market - Major Deal Types

  • 12.1 Collaboration Deals
  • 12.2 Manufacturing Agreement
  • 12.3 Licensing Agreement
  • 12.4 Exclusive Agreement
  • 12.5 Partnerships Deals

13. Companies - Insulin Pump Clinical Trials

  • 13.1 Medtronic
  • 13.2 Insulet Corporation
  • 13.3 Tandem Diabetes Care
  • 13.4 Roche
  • 13.5 Animas Corporation

14. United States - Key Player Analysis

  • 14.1 Medtronic
    • 14.1.1 Overview
    • 14.1.2 Insulin Pump - Product Details
    • 14.1.3 Insulin Pump Sales Analysis (2009 - 2022)
    • 14.1.4 Insulin Pump - Latest Development & Trends
  • 14.2 Insulet Corporation
    • 14.2.1 Overview
    • 14.2.2 Insulin Pump - Product Details
    • 14.2.3 Insulin Pump Sales Analysis (2009 - 2022)
    • 14.2.4 Insulin Pump - Latest Development & Trends
  • 14.3 Roche
    • 14.3.1 Overview
    • 14.3.2 Insulin Pump - Product Details
    • 14.3.3 Insulin Pump Sales Analysis (2009 - 2016)
    • 14.3.4 Insulin Pump - Latest Development & Trends
  • 14.4 Animas Corporation (Acquired by Johnson & Johnson)
    • 14.4.1 Overview
    • 14.4.2 Insulin Pump - Product Details
    • 14.4.3 Insulin Pump Sales Analysis (2009 - 2022)
    • 14.4.4 Insulin Pump - Latest Development & Trends
  • 14.5 Tandem Diabetes Care
    • 14.5.1 Overview
    • 14.5.2 Insulin Pump Product Details
    • 14.5.3 Insulin Pump Sales Analysis (2009 - 2022)
    • 14.5.4 Insulin Pump - Latest Development & Trends

15. Growth Drivers

  • 15.1 Benefits of Insulin Pump over Multiple Daily Injection
  • 15.2 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices

16. Challenges

  • 16.1 Safety Issues in Insulin Pump Devices
  • 16.2 Difficulties Associated with the Pump
    • 16.2.1 Weight Gain
    • 16.2.2 Diabetic Ketoacidosis
    • 16.2.3 Infection and Infusion Site Reactions
  • 16.3 Adherence

List of Figures

  • Figure 2-1: United States - Overall Diabetes Population (Thousand), 2009 - 2016
  • Figure 2-2: United States - Forecast for Overall Diabetes Population (Thousand), 2017 - 2022
  • Figure 2-3: United States - Type 1 Diabetes Population (Thousand), 2009 - 2016
  • Figure 2-4: United States - Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2022
  • Figure 2-5: United States: Type 2 Diabetes Population (Thousand), 2009 - 2016
  • Figure 2-6: Forecast for Type 2 Diabetes Population (Thousand), 2017 - 2022
  • Figure 3-1: United States - Insulin Pump Users (Number), 2009 - 2016
  • Figure 3-2: United States - Forecast for Insulin Pump Users (Number), 2017 - 2022
  • Figure 3-3: United States - Type 1 Users of Insulin Pump (Number), 2009 - 2016
  • Figure 3-4: United States - Forecast for Type 1 Users of Insulin Pump (Number), 2017 - 2022
  • Figure 3-5: United States - Type 2 Users of Insulin Pump (Number), 2009 - 2016
  • Figure 3-6: United States - Forecast for Type 2 Users of Insulin Pump (Number), 2017 - 2022
  • Figure 4-1: United States - Insulin Pump Market (Million US$), 2009 - 2016
  • Figure 4-2: United States - Forecast for Insulin Pump Market (Million US$), 2017 - 2022
  • Figure 4-3: United States - Insulin Pump Type 1 Market (Million US$), 2009 - 2016
  • Figure 4-4: United States - Forecast for Insulin Pump Type 1 Market (Million US$), 2017 - 2022
  • Figure 4-5: United States - Insulin Pump Type 2 Market (Million US$), 2009 - 2016
  • Figure 4-6: United States - Forecast for Insulin Pump Type 2 Market (Million US$), 2017 - 2022
  • Figure 5-1: United States - CGM User (Number), 2009 - 2016
  • Figure 5-2: United States - Forecast for CGM User (Number), 2017 - 2021
  • Figure 6-1: United States - CGM Market (Million US$), 2009 - 2016
  • Figure 6-2: United States - Forecast for CGM Market (Million US$), 2017 - 2022
  • Figure 11-1: United States - Insulin Pump Preferred Brand (Percent) by Company, 2013
  • Figure 14-1: United States - Medtronic Insulin Pump Revenue (Million US$), 2009 - 2016
  • Figure 14-2: United States - Forecast for Medtronic Insulin Pump Revenue (Million US$), 2017 - 2022
  • Figure 14-3: United States - Insulet Corporation Insulin Pump Revenue (Million US$), 2009 - 2016
  • Figure 14-4: United States - Forecast for Insulet Corporation Insulin Pump Revenue (Million US$), 2017 - 2022
  • Figure 14-5: Global - Roche Insulin Pump Revenue (Million US$), 2009 - 2016
  • Figure 14-6: Global - Animas Corporation Insulin Pump Revenue (Million US$), 2009 - 2016
  • Figure 14-7: Global - Forecast for Animas Corporation Insulin Pump Revenue (Million US$), 2017 - 2022
  • Figure 14-8: Global - Tandem Insulin Pump Revenue (Million US$), 2012 - 2016
  • Figure 14-9: Global - Forecast for Tandem Insulin Pump Revenue (Million US$), 2017 - 2022

List of Tables

  • Table 7-1: United States - Animas Vibe Differentiation Features
  • Table 7-2: United States - Medtronic 530G with Enlite Differentiation Features
  • Table 7-3: United States - Insulet OmniPod Differentiation Features
  • Table 7-4: United States - Tandem t:slim Differentiation Features
  • Table 7-5: United States - Roche Accu-Chek Combo Differentiation Features
  • Table 10-1: Blue Cross and Blue Shield - Comparison of Benefits between Standard Option and Basic Option
  • Table 10-2: Blue Cross and Blue Shield - Insulin Pump Coverage
  • Table 14-1: Medtronic - Latest Insulin Pump Products
  • Table 14-2: Insulet Corporation - Latest Products
  • Table 14-3: Roche Insulin Pump - Latest Products
  • Table 14-4: Animas Corporation Insulin Pump - Latest Products
  • Table 14-5: Tandem Insulin Pump - Latest Products
Back to Top